These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
131 related items for PubMed ID: 35197338
1. Analysis of eGFR index category and annual eGFR slope association with adverse clinical outcomes using real-world Japanese data: a retrospective database study. Zhang L, Hauske S, Ono Y, Kyaw MH, Steubl D, Naito Y, Kanasaki K. BMJ Open; 2022 Feb 23; 12(2):e052246. PubMed ID: 35197338 [Abstract] [Full Text] [Related]
2. Is there a correlation between an eGFR slope measured over a 5-year period and incident cardiovascular events in the following 5 years among a Flemish general practice population: a retrospective cohort study. Van Pottelbergh G, Mamouris P, Opdeweegh N, Vaes B, Goderis G, Van Den Akker M. BMJ Open; 2018 Nov 12; 8(11):e023594. PubMed ID: 30420350 [Abstract] [Full Text] [Related]
3. The relationship between eGFR slope and subsequent risk of vascular outcomes and all-cause mortality in type 2 diabetes: the ADVANCE-ON study. Oshima M, Jun M, Ohkuma T, Toyama T, Wada T, Cooper ME, Hadjadj S, Hamet P, Harrap S, Mancia G, Marre M, Williams B, Chalmers J, Woodward M, Perkovic V, ADVANCE Collaborative Group. Diabetologia; 2019 Nov 12; 62(11):1988-1997. PubMed ID: 31302707 [Abstract] [Full Text] [Related]
4. Slope of Kidney Function and Its Association with Longitudinal Mortality and Cardiovascular Disease among Individuals with CKD. Orlandi PF, Xie D, Yang W, Cohen JB, Deo R, Ricardo AC, Schrauben S, Wang X, Hamm LL, He J, Sondheimer JH, Kallem K, Townsend R, Raj D, Parsa A, Anderson AH, Feldman HI, CRIC Study Investigators, Chronic Renal Insufficiency Cohort (CRIC) Study Investigators. J Am Soc Nephrol; 2020 Dec 12; 31(12):2912-2923. PubMed ID: 33023926 [Abstract] [Full Text] [Related]
5. The presence and impact of multimorbidity clusters on adverse outcomes across the spectrum of kidney function. Sullivan MK, Carrero JJ, Jani BD, Anderson C, McConnachie A, Hanlon P, Nitsch D, McAllister DA, Mair FS, Mark PB, Gasparini A. BMC Med; 2022 Nov 01; 20(1):420. PubMed ID: 36320059 [Abstract] [Full Text] [Related]
6. eGFR slope as a surrogate endpoint for clinical study in early stage of chronic kidney disease: from The Japan Chronic Kidney Disease Database. Itano S, Kanda E, Nagasu H, Nangaku M, Kashihara N. Clin Exp Nephrol; 2023 Oct 01; 27(10):847-856. PubMed ID: 37466813 [Abstract] [Full Text] [Related]
7. Association between estimated glomerular filtration rate slope and cardiovascular disease among individuals with and without diabetes: a prospective cohort study. Ramezankhani A, Azizi F, Hadaegh F. Cardiovasc Diabetol; 2023 Oct 04; 22(1):270. PubMed ID: 37794456 [Abstract] [Full Text] [Related]
8. Development of a machine learning-based prediction model for extremely rapid decline in estimated glomerular filtration rate in patients with chronic kidney disease: a retrospective cohort study using a large data set from a hospital in Japan. Inaguma D, Hayashi H, Yanagiya R, Koseki A, Iwamori T, Kudo M, Fukuma S, Yuzawa Y. BMJ Open; 2022 Jun 09; 12(6):e058833. PubMed ID: 35680264 [Abstract] [Full Text] [Related]
9. Association of eGFR slope with all-cause mortality, macrovascular and microvascular outcomes in people with type 2 diabetes and early-stage chronic kidney disease. Jin Q, Kuen Lam CL, Fai Wan EY. Diabetes Res Clin Pract; 2023 Nov 09; 205():110924. PubMed ID: 37778664 [Abstract] [Full Text] [Related]
10. Cardiovascular and renal safety of metformin in patients with diabetes and moderate or severe chronic kidney disease: Observations from the EXSCEL and SAVOR-TIMI 53 cardiovascular outcomes trials. Clegg LE, Jing Y, Penland RC, Boulton DW, Hernandez AF, Holman RR, Vora J. Diabetes Obes Metab; 2021 May 09; 23(5):1101-1110. PubMed ID: 33394543 [Abstract] [Full Text] [Related]
11. Creatinine- and cystatin C-based estimated glomerular filtration rate slopes for the prediction of kidney outcome: a comparative retrospective study. Kim S, Hwang S, Jang HR, Sohn I, Ahn HS, Park HD, Huh W, Jin DC, Kim YG, Kim DJ, Oh HY, Lee JE. BMC Nephrol; 2019 Jun 11; 20(1):214. PubMed ID: 31185945 [Abstract] [Full Text] [Related]
12. Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis. Black C, Sharma P, Scotland G, McCullough K, McGurn D, Robertson L, Fluck N, MacLeod A, McNamee P, Prescott G, Smith C. Health Technol Assess; 2010 Apr 11; 14(21):1-184. PubMed ID: 20441712 [Abstract] [Full Text] [Related]
13. Kidney outcomes associated with use of SGLT2 inhibitors in real-world clinical practice (CVD-REAL 3): a multinational observational cohort study. Heerspink HJL, Karasik A, Thuresson M, Melzer-Cohen C, Chodick G, Khunti K, Wilding JPH, Garcia Rodriguez LA, Cea-Soriano L, Kohsaka S, Nicolucci A, Lucisano G, Lin FJ, Wang CY, Wittbrodt E, Fenici P, Kosiborod M. Lancet Diabetes Endocrinol; 2020 Jan 11; 8(1):27-35. PubMed ID: 31862149 [Abstract] [Full Text] [Related]
14. Early Trajectory of Estimated Glomerular Filtration Rate and Long-term Advanced Kidney and Cardiovascular Complications in Type 1 Diabetes. Perkins BA, Bebu I, Gao X, Karger AB, Hirsch IB, Karanchi H, Molitch ME, Zinman B, Lachin JM, de Boer IH. Diabetes Care; 2022 Mar 01; 45(3):585-593. PubMed ID: 35015817 [Abstract] [Full Text] [Related]
15. First-year estimated glomerular filtration rate variability after pre-end-stage renal disease program enrollment and adverse outcomes of chronic kidney disease. Tsai CW, Huang HC, Chiang HY, Chung CW, Chiu HT, Liang CC, Yu T, Kuo CC. Nephrol Dial Transplant; 2019 Dec 01; 34(12):2066-2078. PubMed ID: 29982714 [Abstract] [Full Text] [Related]
16. Association between renal function and cardiovascular and all-cause mortality in the community-based elderly population: results from the Specific Health Check and Guidance Program in Japan. Kon S, Konta T, Ichikawa K, Asahi K, Yamagata K, Fujimoto S, Tsuruya K, Narita I, Kasahara M, Shibagaki Y, Iseki K, Moriyama T, Kondo M, Watanabe T. Clin Exp Nephrol; 2018 Apr 01; 22(2):346-352. PubMed ID: 28744566 [Abstract] [Full Text] [Related]
17. Estimated Glomerular Filtration Rate, Cardiovascular Events and Mortality Across Age Groups Among Individuals Older Than 60 Years in Southern Europe. Salvador-González B, Gil-Terrón N, Cerain-Herrero MJ, Subirana I, Güell-Miró R, Rodríguez-Latre LM, Cunillera-Puértolas O, Elosua R, Grau M, Vila J, Pascual-Benito L, Mestre-Ferrer J, Ramos R, Baena-Díez JM, Soler-Vila M, Alonso-Bes E, Ruipérez-Guijarro L, Álvarez-Funes V, Freixes-Villaró E, Rodríguez-Pascual M, Martínez-Castelao A. Rev Esp Cardiol (Engl Ed); 2018 Jun 01; 71(6):450-457. PubMed ID: 29111335 [Abstract] [Full Text] [Related]
18. Reduction of Cardiovascular Risk and Improved Estimated Glomerular Filtration Rate by SGLT2 Inhibitors, Including Dapagliflozin, Is Consistent Across the Class: An Analysis of the Placebo Arm of EXSCEL. Clegg LE, Heerspink HJL, Penland RC, Tang W, Boulton DW, Bachina S, Fox RD, Fenici P, Thuresson M, Mentz RJ, Hernandez AF, Holman RR. Diabetes Care; 2019 Feb 01; 42(2):318-326. PubMed ID: 30523029 [Abstract] [Full Text] [Related]
19. Preoperative renal dysfunction and mortality after non-cardiac surgery. Prowle JR, Kam EP, Ahmad T, Smith NC, Protopapa K, Pearse RM. Br J Surg; 2016 Sep 01; 103(10):1316-25. PubMed ID: 27346181 [Abstract] [Full Text] [Related]
20. Kidney, Cardiac, and Safety Outcomes Associated With α-Blockers in Patients With CKD: A Population-Based Cohort Study. Hundemer GL, Knoll GA, Petrcich W, Hiremath S, Ruzicka M, Burns KD, Edwards C, Bugeja A, Rhodes E, Sood MM. Am J Kidney Dis; 2021 Feb 01; 77(2):178-189.e1. PubMed ID: 32920153 [Abstract] [Full Text] [Related] Page: [Next] [New Search]